Filter Results
Related Organization
- Biological and Environmental Systems Science Directorate (23)
- Computing and Computational Sciences Directorate (35)
- Energy Science and Technology Directorate (217)
- Fusion and Fission Energy and Science Directorate (21)
- Information Technology Services Directorate (2)
- National Security Sciences Directorate
(17)
- Neutron Sciences Directorate (11)
- Physical Sciences Directorate (128)
- User Facilities (27)
- (-) Isotope Science and Enrichment Directorate (6)
Researcher
- Mike Zach
- Aaron Werth
- Alexander I Kolesnikov
- Ali Passian
- Andrew F May
- Bekki Mills
- Ben Garrison
- Brad Johnson
- Bruce Moyer
- Charlie Cook
- Christopher Hershey
- Craig Blue
- Daniel Rasmussen
- Debjani Pal
- Emilio Piesciorovsky
- Gary Hahn
- Harper Jordan
- Hsin Wang
- James Klett
- Jeffrey Einkauf
- Jennifer M Pyles
- Joel Asiamah
- Joel Dawson
- John Lindahl
- John Wenzel
- Justin Griswold
- Kuntal De
- Laetitia H Delmau
- Luke Sadergaski
- Mark Loguillo
- Matthew B Stone
- Nance Ericson
- Nedim Cinbiz
- Padhraic L Mulligan
- Raymond Borges Hink
- Sandra Davern
- Srikanth Yoginath
- Tony Beard
- Varisara Tansakul
- Victor Fanelli
- Yarom Polsky

Ruthenium is recovered from used nuclear fuel in an oxidizing environment by depositing the volatile RuO4 species onto a polymeric substrate.

Neutron scattering experiments cover a large temperature range in which experimenters want to test their samples.

The technologies provide a system and method of needling of veiled AS4 fabric tape.

Neutron beams are used around the world to study materials for various purposes.

Spherical powders applied to nuclear targetry for isotope production will allow for enhanced heat transfer properties, tailored thermal conductivity and minimize time required for target fabrication and post processing.

ORNL will develop an advanced high-performing RTG using a novel radioisotope heat source.

Electrical utility substations are wired with intelligent electronic devices (IEDs), such as protective relays, power meters, and communication switches.

Biocompatible nanoparticles have been developed that can trap and retain therapeutic radionuclides and their byproducts at the cancer site. This is important to maximize the therapeutic effect of this treatment and minimize associated side effects.